Using Rodent Behavorial Models To Identify Tender in USA - 20322489

Procurement Summary

Country: USA

Summary: Using Rodent Behavorial Models To Identify Substance Abuse Pharmacotherapies

Deadline: 12 Feb 2018

Posting Date: 08 Feb 2018

Other Information

Notice Type: Tender

TOT Ref.No.: 20322489

Document Ref. No.: N01DA-18-8936

Competition: ICB

Financier: Self Financed

Purchaser Ownership: -

Tender Value: Refer Document

CPV Classification

73110000 - Research services

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Using Rodent Behavorial Models To Identify Substance Abuse Pharmacotherapies
Nida intends to solicit proposals for preclinical evaluation of test compounds as potential pharmacotherapies for substance abuse. To this end, the offeror and technical personnel need to have the capability and experience to conduct experiments evaluating compounds in the mouse locomotor activity, rat drug discrimination, rat conditioned place preference, mouse stressed-inducted potentiation of conditioned place preference, and rat self-administration paradigms. The offeror and technical staff also need to have experience conducting these types of experiments using cocaine, methamphetamine, nicotene, thc, and hallucinogens. Evidence of experience must be documented through publications using the relevant behavioral models listed above. In addition, the offeror needs to have the dedicated laboratory space, animal care facilities, and equipment required to conduct these behavorial assays. Proprietary compounds will be evaluated using established protocols, and the resulting data will be utilized by the addiction treatment discovery program (atdp) of the nida division of therapeutics and medical consequences (dtmc).
Mandatory criteria;
1. Drug enforcement administration (dea) research registration; this project involves the use of scheduled drugs under the controlled substances act of 1970. Due to the nature of the compounds which will be evaluated under this contract, it is mandatory that offerors possess at the time of award a dea research registration for schedules ii to v in order to handle substances under the controlled substances act of 1970. In addition, the offerors must either possess or demonstrate the ability to obtain a dea registration for schedule i controlled substances.
2. Animal welfare: this research involves the use of animals. The offeror must demonstrate its understanding and compliance with the nih guide for care and use of laboratory animals. The offeror shall submit evidence that its proposal was reviewed and approved by the instit...

Documents

 Tender Notice